induced by either genetic factors or environmental stressors. 1 The clinical symptoms often appear after adolescence period, which can be predicted by abnormal pattern of brain activities prior to the first psychotic episode. 2 Psychological intervention, pharmacological agents, behavioral therapies, and Invasive brain stimulation (eg, DBS) act as potential tools to reduce the schizophrenia development for population at high risk.
Risk of Schizophrenia originates from neurodevelopmental deficits
induced by either genetic factors or environmental stressors. 1 The clinical symptoms often appear after adolescence period, which can be predicted by abnormal pattern of brain activities prior to the first psychotic episode. 2 Psychological intervention, pharmacological agents, behavioral therapies, and Invasive brain stimulation (eg, DBS) act as potential tools to reduce the schizophrenia development for population at high risk. [3] [4] [5] In recent decade, noninvasive brain stimulation has been employed as potential treatments against cognitive deficits and negative symptoms in schizophrenia patients. 6 Yet it is unclear if noninvasive brain stimulation could prevent schizophrenia development and progression as well. In a recent study by Hadar et al published on
Molecular Psychiatry, the authors set out to demonstrate the possibility of adolescent period brain stimulation-based prevention of schizophrenia development. phenotypes. It will also be helpful to measure the monoamine and neurotrophic factor release levels at multiple sites of the brain following tDCS treatment sessions.
